Showing results (1861-1870 of 2,043) with videos related to

Sort By:
Pageof 205
ACS Nano|February 13, 2023
Dual Optimization of Bulk and Interface via the Synergistic Effect of Ligand Anchoring and Hole Transport Dopant Enables 23.28% Efficiency Inverted Perovskite Solar CellsXianyong Zhou, Xiangfeng Luan, Luozheng Zhang, et al.
Plos One|January 14, 2014
n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's diseaseRu-Huei Fu, Horng-Jyh Harn, Shih-Ping Liu, et al.
Journal of Integrative Medicine|February 3, 2024
Transcutaneous electrical acupoint stimulation benefits postoperative pain relief of oocyte retrieval: A randomized controlled trialLi-Ying Liu, Yang Su, Rong-Rong Wang, et al.
Scientific Reports|November 10, 2016
High brightness formamidinium lead bromide perovskite nanocrystal light emitting devicesAjay Perumal, Sushant Shendre, Mingjie Li, et al.
Anticancer Research|September 10, 2014
Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patientsChih-Chieh Hsu, Chiao-En Wu, Jen-Shi Chen, et al.
Japanese Journal of Clinical Oncology|August 22, 2015
The impact of pain control on physical and psychiatric functions of cancer patients: a nation-wide survey in TaiwanKun-Ming Rau, Jen-Shi Chen, Hung-Bo Wu, et al.
Virulence|May 22, 2020
UvrY is required for the full virulence of Aeromonas dhakensisYi-Wei Chen, Wen-Hsuan Yeh, Hung-Jen Tang, et al.
The Journal of Cell Biology|June 19, 2013
The tumor suppressor CDKN3 controls mitosisGrzegorz Nalepa, Jill Barnholtz-Sloan, Rikki Enzor, et al.
The Journal of Biological Chemistry|May 31, 2020
Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1Julie A Mund, SuJung Park, Abbi E Smith, et al.
British Journal of Cancer|July 2, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trialChia-Jui Yen, Ming-Huang Chen, Yen-Yang Chen, et al.
Pageof 205